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Abstract 
Background 
The Src family tyrosine kinases (SFK) are cellular regulatory proteins that influence cell 
adhesion, proliferation, invasion and survival during tumor development. Elevated activity of 
Src was associated with increased cell proliferation and invasivity in human papillomavirus 
(HPV)-associated malignancies; therefore, transduced human foreskin keratinocytes (HFK) 
were used to investigate whether SFK activation is a downstream effect of papillomaviral 
oncoproteins. Activation of ubiquitously expressed SFKs, namely Src, Yes and Fyn, was 
investigated in both proliferating and differentiating keratinocytes. 
Results 
In proliferating keratinocytes, Src, Yes and Fyn mRNA levels were not affected by HPV 16 
E6 or E7 oncoproteins, while at the protein level as detected by western blot, the presence of 
both E6 and E7 resulted in substantial increase in Src and Yes expression, but did not alter 
the high constitutive level of Fyn. Phospo-kinase array revealed that all ubiquitously 
expressed SFKs are activated by phosphorylation in the presence of HPV 16 E7 oncoprotein. 
Keratinocyte differentiation led to increased Yes mRNA and protein levels in all transduced 
cell lines, while it did not influence the Src transcription but resulted in elevated Src protein 
level in HPV16 E7 expressing lines. 
Conclusions 
This study revealed that HPV 16 oncoproteins upregulate Src family kinases Src and Yes via 
posttranscriptional mechanisms. A further effect of HPV 16 E7 oncoprotein is to enhance the 
activating phosphorylation of SFKs expressed in keratinocytes. 
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Background 
The Src family cytoplasmic tyrosine kinases (SFK) are important signal transducers that are 
activated by many different classes of cell-surface receptors including receptor tyrosine 
kinases, cytokine receptors, and integrin extracellular matrix receptors [1-3]. This kinase 
family consists of 11 homologous non-receptor tyrosine kinases, namely Src, Fyn, Yes, Blk, 
Yrk, Frk, Fgr, Hck, Lck, Srm, and Lyn. Src, Fyn and Yes appear to be ubiquitously expressed 
in many different cell lineages, including keratinocytes of the squamous epithelium. SFKs are 
activated primarily via protein-protein interactions involving their SH2 domains, followed by 
a trans-autocatalytic phosphorylation of a conserved tyrosine residue in their catalytic domain 
[4,5]. SFKs interact with a network of intracellular pathways influencing cell adhesion, 
growth, movement and differentiation, therefore, SFKs may exhibit oncogenic activity when 
they become overactivated [6-8]. This overactivation is frequently detected in solid tumors 
where it has been associated with advanced disease stages and metastatic potential [9]. 
Therefore, small molecule inhibitors of SFKs were developed and tested successfully in some 
cancer types including ovarian, prostate, skin, hepatocellular, pancreatic, and non-small cell 
lung cancer for suppression of neoplastic cell proliferation and invasive capacity [10-15]. 
Recent studies have demonstrated elevated Src activity in cervical cancer tissues, and 
treatment with Src kinase inhibitors caused decreased cell motility and invasion abilities of 
cervical cancer cell lines [16-18]. Thus, Src inhibitors are considered as promising therapy 
molecules also for human cervical carcinomas [19]. However, the factors inducing SFK 
upregulation in cervical cancer, the second leading cause of death from cancer in women 
worldwide, are still to be clarified. 
The major etiological factors of cervical cancer are human papillomaviruses (HPV), as nearly 
100% of cervical cancers are positive for high-risk HPVs, HPV16 and HPV18 being the most 
prevalent genotypes detected in cervical carcinomas [20]. HPVs are considered as the most 
prevalent sexually transmitted infectious agents and are also frequently associated with other 
anogenital and oropharyngeal malignancies [21]. HPVs are small, non-enveloped DNA 
viruses that infect the cutaneous and mucosal epithelia with a life cycle tightly linked to the 
differentiation of the host epithelial cell [22]. Persistent high-risk HPV infection of epithelial 
cells results in permanent expression of the E6 and E7 viral oncoproteins, which play crucial 
roles in the induction and the maintenance of malignant transformation of the host cell 
[23,24]. The E6 and E7 oncoproteins of high-risk HPV viruses are able to reprogram their 
host cell regulatory pathways via associating with several signaling molecules involved in the 
regulation of cell-cycle progression and cellular differentiation, thereby promoting abnormal 
cell proliferation and neoplastic transformation [23,25]. This property of HPV oncoproteins 
raises the question whether the activation of SFKs in cervical cancer tissues and cell lines is a 
downstream effect of papillomaviral oncoproteins or it develops later during the oncogenic 
clonal selection. 
In the present study, we investigated both the expression and the activation by 
phosphorylation of the ubiquitously expressed SFKs, namely Src, Yes, and Fyn in retrovirus 
transduced keratinocytes expressing HPV 16 E6, E7 or both oncoproteins under proliferating 
and differentiating culture conditions. Src and Yes expression was influenced differently by 
papillomaviral oncoproteins and differentiation, whereas the constitutively high Fyn 
expression was not affected by them. Nevertheless, the phosphorylation of the above SFKs 
was uniformly increased in the presence of E7 oncoprotein. 
Results 
Effect of HPV 16 E6 and E7 on the expression of Src family kinases in human 
keratinocytes 
Human foreskin keratinocytes (HFK) expressing HPV 16 oncoproteins were tested for the 
expression and the activity of SFKs. HFK cells were transduced by recombinant retroviruses 
carrying either the empty control vector (LXSN) or vectors encoding HPV 16 E6, E7 or both 
oncogenes as described previously [26]. The cell lines were cultured in serum-free medium to 
maintain proliferation. The presence of functionally active E6 and E7 oncoproteins in the 
studied cells was confirmed by Western blot analysis revealing altered expression of their 
main targets, the cellular p53 and Rb tumor suppressor proteins, respectively (Figure 1A). 
Substantial reduction of p53 protein level indicated that E6 transduced cell lines indeed 
expressed the functional oncoprotein. Analogously, the presence of functional E7 was 
indicated by decreased level of Rb protein. 
Figure 1 Presence of HPV 16 E6 and E7 has different effect on SFK protein and mRNA 
expression in proliferating human keratinocytes. (A) Western blot analysis of human 
foreskin keratinocytes (HFK) transduced with HPV 16 E6, E7 or both oncogenes. Levels of 
cellular p53 and Rb proteins are reduced in the presence of functionally active HPV 16 E6 
and E7 oncoproteins, respectively. (B) Analysis of Src, Yes, and Fyn protein expression by 
western blot using antibodies specific for the native form of the kinases and for a C-terminal 
tyrosine residue that is phosphorylated upon activation. Actin was used as loading control. 
The results shown are representative of three independent experiments. (C) The effect of 
HPV 16 oncogenes on the relative mRNA expression of ubiquitously expressed SFKs in 
HFK cells. Real-time PCR analysis of Src, Yes, and Fyn was performed using RNA purified 
from HPV 16 E6 and/or E7 transduced HFK cells. The values were normalized against 
GAPDH mRNA and presented as relative levels with respect to the value of cells transduced 
by LXSN. The bars represent the mean ± SEM of two independent experiments, each with 
triplicate measurements. Two-tailed Student t test revealed no significant, HPV related 
alteration in any of the tested SFK mRNA levels. 
In light of recent publications indicating that certain SFKs might be overactivated during the 
process of HPV-associated cervical carcinogenesis [16-18], we examined both the individual 
and the combined effects of HPV 16 E6 and E7 oncoproteins on the expression and activity 
of ubiquitously expressed SFKs, namely Src, Yes, and Fyn. Western blot analysis revealed 
that there was a significant increase in Src and Yes protein levels in the presence of both 
oncogenes, compared to the cells containing the empty vector or only one of the oncogenes 
(Figure 1B). A constitutively high level of Fyn protein was observed in all the studied cell 
lines suggesting that E6 and E7 oncoproteins have little, if any further effect on Fyn 
expression in human keratinocytes. Western blot analysis using phospho-Src antibody 
revealed that SFK activation by phosphorylation required E7 but was independent form E6 
function. The applied antibody can detect both Src phosphorylated at Y416 and other SFKs 
phosphorylated at homologous tyrosine residues. Since both the steady state level and the 
activation state of two SFKs, Src and Fyn were affected by HPV 16 oncoproteins, we also 
quantitated the RNA transcripts of the studied SFKs. Nevertheless, the quantitative RT-PCR 
analysis could not reveal transcriptional mechanisms behind the different protein levels, the 
HPV 16 oncoproteins did not alter significantly the transcription of either SFK (Src, Yes) 
with inducible protein level, and the HPV related transcriptional pattern of Src was very 
similar to that of Fyn with constitutively high protein level (Figure 1C). 
Effect of HPV 16 E6 and E7 on the phosphorylation of Src family kinases in 
human keratinocytes 
Since western blot analysis revealed that the presence of HPV 16 E7 is associated with 
elevated SFK phosphorylation in HFK cells, we wished to evaluate the effect of E6 and E7 
oncoproteins on the phosphorylation state of the individual members of the Src family on 
those tyrosine residues that are phosphorylated upon activation and therefore indicating 
increased kinase activity. To this end, human phospho-kinase array was performed from 
whole cell lysates. The results showed that in the presence of E7 there was a significant 
increase in the phosphorylation levels of all three ubiquitously expressed SFKs, while E6 had 
no effect on their activating phosphorylation when compared to control cells (Figure 2A-B). 
Figure 2 Human phospho- kinase array to study the effect of HPV16 E6 and E7 on the 
phosphorilation state of SFKs. (A) Whole cell lysates were analyzed with a human 
phospho-kinase array to detect phosporylation state of SFKs in HFK cells transduced with 
HPV 16 E6 or E7 or both oncogenes. Signals of tyrosine phosphorilated SFKs are indicated 
in the membranes, and intensity of corresponding spots are presented as bar graphs. (B) Spot-
densities of phosphoproteins were quantified by using ImageJ software and compared to 
those of LXSN control spots. Data are presented as mean ± SEM of two independent 
experiments with duplicates. 
The phospho-kinase array also provided further information on activating phosphorylation of 
relevant proteins such as p53 and four other SFKs. As expected, the level of p53 protein 
phosphorylated at serine residues S15, S46 or S392 increased in the presence of E7 
oncoprotein and reflected well the p53 degradation in the presence of E6 (Figure 3A-B). The 
p53 phosphorylation pattern assisted the study in two ways: first, it further confirmed the 
eligibility of the transduced cell lines for papillomaviral functional analysis; second, it 
revealed that the capture based array could measure even the phosphorylated fraction of 
protein levels hardly or not detected by western blot. 
Figure 3 Effect of HPV 16 E6 and E7 on the phosphorilation state of p53. (A) p53 
phosphorilation at serine residues S392, S46, and S15 detected by phosho-kinase array. 
Different phosphorilation variants of p53 are indicated by arrows in the membranes, and 
intensity of corresponding spots are presented as graphics (B). Spot-densities of 
phosphoproteins were quantified by using ImageJ software and compared to those of LXSN 
control spots. Data are presented as mean ± SEM of two independent experiments with 
duplicates. 
The other extra information obtained from the phospho-kinase array was the detection of four 
other SFKs, namely Lyn, Lck, Fgr, and Hck, which tend to be expressed in cells of lymphoid 
origin. All transduced keratinocyte lines lacked activated Lyn, Lck and Fgr non-receptor 
tyrosine kinases, while some spot densities could be detected for activated Hck in the 
presence of E7 (Figure 2A). Hck mRNA could also be detected independently from 
papillomaviral oncoproteins (data not shown); however, the Hck protein level was below the 
detection limit of western blot suggesting a minor role for this member of the family in 
keratinocytes. 
Cellular differentiation alters expression of SFKs in keratinocytes expressing 
HPV16 E6, E7 or both oncoproteins 
Next, we studied whether the effect of HPV 16 E6 and E7 oncoproteins on the expression and 
activity of Src, Yes and Fyn could be affected by cellular differentiation. Human 
keratinocytes transduced by HPV 16 E6, E7 or both oncogenes were cultured in the presence 
of serum and high calcium to induce cellular differentiation. In the tested cell cultures, 
successful initiation of cellular differentiation was confirmed as described previously [26]. 
First we confirmed that the activities of E6 and E7 oncoproteins were maintained in 
differentiating cells as well. Concomitant with the presence of E6 or E7, decreased levels of 
p53 or pRb proteins could be observed, respectively (Figure 4A). 
Figure 4 Differentiation of human keratinocytes influences SFK protein and mRNA 
expression in transduced HFK cells. (A) Western blot analysis of differentiating human 
foreskin keratinocytes (HFK) transduced with HPV 16 E6, E7 or both oncogenes. Cellular 
differentiation was induced by culturing cells in the presence of serum and high calcium. 
Levels of cellular p53 and Rb proteins are reduced in the presence of functionally active HPV 
16 E6 and E7 oncoproteins, respectively. (B) Analysis of Src, Yes, and Fyn protein 
expression by western blot using antibodies specific for the native form of the kinases and for 
a C-terminal tyrosine residue that is phosphorylated upon activation. Actin was used as 
loading control. The results shown are representative of three independent experiments. (C) 
The effect of HPV 16 oncogenes on the relative mRNA expression of Src, Yes, and Fyn in 
differentiating HFK cells. Real-time PCR analysis was performed using RNA purified from 
the transduced HFK cells. The values were normalized against GAPDH mRNA and 
presented as relative levels with respect to the value of cells transduced by LXSN. The bars 
represent the mean ± SEM of two independent experiments, each with triplicate 
measurements. Two-tailed Student t-test was carried out for the analysis of mRNA 
expression levels to determine statistical significance (P < 0.05). 
In differentiating keratinocytes, Src protein expression was upregulated in a similar manner 
to that in proliferating keratinocytes except the presence of E7 alone was sufficient to induce 
upregulation (Figure 4B). Neither differentiation, nor the presence of papillomaviral 
oncoproteins resulted in significantly altered Src mRNA levels. (Figure 4C). On the other 
hand, differentiation upregulated Yes protein expression to a level not influenced by 
papillomaviral oncoproteins (Figure 4B). Yes upregulation involved also transcriptional 
mechanisms, differentiation itself resulted in significant increase (P < 0.05) in Yes mRNA 
levels. Unlike in proliferating HFK lines, presence of E6 in the differentiating lines was 
significantly (P < 0.05) associated with increased Yes mRNA expression (Figure 4C). 
However, this transcriptional effect of E6 did not result in detectable alteration of Yes protein 
level (Figure 4B). Fyn protein level, likewise in proliferating HFK cells, was constitutively 
high and independent from papillomaviral oncoproteins (Figure 4B). Fyn mRNA level was 
also significantly increased (P < 0.05) in differentiating keratinocytes but it was not 
significantly altered in the presence papillomaviral oncoproteins (Figure 4C). Although 
differentiation of keratinocytes proved to act as a further regulatory mechanism for the 
expression of certain SFKs, it left SFK phosphorylation unaffected (Figure 4B). 
Discussion 
This study identified Src family non-receptor tyrosine kinases (SFKs) that are activated in the 
presence of HPV 16 oncoproteins. Enhanced activity of SFKs has been detected in a wide 
range of malignancies including cervical cancer , where the most studied member of the 
family, Src was shown to be overactive based on the presence of activating phosphorylation 
at Y416 [5,7,8]. Besides Src, this kinase family involves two other ubiquitously expressed 
non-receptor tyrosine kinases, namely Yes and Fyn, which are expressed in various cell types 
including keratinocytes. Although Yes and Fyn have not yet been studied in cervical cancer, 
they are overactivated in several malignancies. For instance, Yes kinase has been associated 
with increased cell proliferation and invasion of human melanoma and colon carcinoma cells 
[9,27] and Fyn kinase has been implicated in the progression and metastasis of prostate 
cancer [14]. Since activation of SFKs occurs by phosphorylation at a C-terminal Y416 
residue of Src and at homologous tyrosine residues of the other members of the family, 
therefore, in our experiments we also used a phospho-SFK specific antibody to assess the 
changes in the overall activity of the SFKs, then we refined the individual activation state of 
these kinases. 
In this study, transduction of primary human keratinocytes ensured the detection of early 
downstream effects of the papillomaviral oncogenes in the natural host cells. The 
experiments were performed from 5 to 8 passages after transduction, therefore, our 
observations were probably unaffected by clonal expansion of any random genomic 
alteration. Primary human keratinocytes can also be driven towards differentiation, which 
leads to changes similar to those in the upper layers of the stratified squamous epithelium. 
Differentiating squamous cells lose their ability to proliferate and to replicate DNA which 
results in an intracellular condition targeted and reverted by papillomaviral oncoproteins. 
This mechanism ensures the effective viral replication in natural HPV infection [28,29]. As 
previously shown, the applied method was suitable to induce keratinocyte differentiation, 
thus, the differentiating keratinocyte cultures were considered to represent the upper layers, 
while the proliferating cultures to represent the basal layer of the squamous epithelium [26]. 
Cervical carcinogenesis has the unique feature of requiring papillomaviral i.e. exogenous 
oncoproteins from initiation to final stage. The E6 and E7 oncoproteins of the high-risk HPV 
types promote viral replication by interacting with cellular regulatory proteins [25]. More 
specifically, association of high-risk E6 with tumor suppressor protein p53 leads to the 
proteasomal degradation of p53 via recruitment of an ubiquitin ligase, E6-AP. In addition, 
p53-independent activities of E6 such as telomerase activation, association with PDZ proteins 
and other cellular target proteins may also contribute to the oncogenic activities of high-risk 
E6 proteins [30,31]. High-risk E7 oncoprotein is able to promote neoplastic transformation 
mainly by binding and subsequently promoting the proteasome-mediated degradation of the 
hypophosphorylated, growth suppressive form of the retinoblastoma tumor suppressor protein 
(pRb, p105) and the related pocket proteins p107 and pRb2/p130, thus, causing aberrant S-
phase entry in cells that would have normally withdrawn from the cell division cycle. Besides 
pRb, E7 can also associate and interfere with the activities of multiple cellular factors, such 
as AP1, HDAC-1, PCAF, BRCA1, CDK, and ATM that contribute to the dysregulation of the 
cell cycle and apoptosis, and cause genomic instability [25,32]. In this study, the levels of 
p53 and pRb tumor suppressor proteins in the transduced cells were used to demonstrate the 
presence of functional E6 and E7, respectively. 
The key role of papillomaviral oncoproteins in cervical carcinogenesis, the ubiquitous 
availability of Src, Fyn and Yes non-tyrosine receptor kinases and the observed Src activation 
in cervical cancer suggest a link between these important oncogenic factors and the 
papillomaviral oncoproteins. Indeed, increased Src Y416 phosphorylation has been observed 
in both established cell lines (SiHa, HeLa) and biopsies of cervical carcinoma origin [16]. 
The importance of SFK activation during cervical carcinogenesis is further supported by the 
notion that treatment with a small molecule Src kinase inhibitor or suppression of Src mRNA 
by siRNA treatment inhibited the proliferation of cervical cancer cell lines HeLa and SiHa 
[16]. Yasmeen and colleagues demonstrated that treatment of the above mentioned cervical 
carcinoma cell lines with Src kinase inhibitors significantly decreases cell motility and 
invasion abilities, as well [18]. Furthermore, nude mice xenograft experiments using HeLa 
cells showed that Src kinase inhibitors can also inhibit subcutaneous tumor growth 
significantly [16,17]. Despite the accumulating evidence regarding the importance of Src 
activation during cervical carcinogenesis, it is still not known whether the activation of Src 
and other SFKs in cervical cancer tissues and established cell lines is linked to papillomaviral 
oncoproteins or it develops later during the oncogenic clonal selection. 
To investigate the involvement of high-risk HPV oncoproteins in SFK activation, first the 
effect of HPV 16 E6 and E7 oncoproteins was analyzed on SFK protein expression in 
transduced human primary keratinocytes, which revealed a heterogeneous response by Src, 
Yes and Fyn. In details, Src and Yes had similar requirement for both E6 and E7 to be 
upregulated in proliferating but not in differentiating keratinocytes. The latter condition itself 
made all transduced cell lines upregulate Yes protein expression with no further effect by 
papillomaviral oncoproteins. For Src upregulation, differentiation maintained the necessity of 
E7 activity but abrogated that of E6. Fyn protein expression was not influenced by the studied 
papillomaviral oncoproteins at all. Noteworthy, mRNA alterations could not be identified in 
the background of HPV 16 mediated SFK upregulation suggesting the importance of 
posttranscriptional regulatory mechanisms. 
Despite the heterogenous effects on the protein expression, activation of Src, Yes and Fyn by 
phosphorylation was uniformly dependent on the presence of HPV 16 E7. Thus, the HPV 16 
E7 oncoprotein, assisted also by the E6, might have dual effect on SFK activity. It can 
activate constitutively available non receptor tyrosine kinase Fyn and it can also elevate the 
intracellular level of others such as Src and Yes. Being available, Src, Yes and Fyn are 
uniformly activated by phosphorylation on Y416 and homologous tyrosine residues, 
respectively, in the presence of HPV 16 E7. 
In this study, we observed HPV related alterations in the protein expression and activation of 
SFKs as a phenomenon. Underlying mechanisms can be proposed based on other studies. Our 
results on HPV mediated SFK activation are in agreement with a recent study where a kinase 
screen performed in HPV 16 E7 expressing RKO colorectal carcinoma cell lines revealed, 
that HPV 16 E7 expression results in substantially altered kinase requirements for viability of 
RKO cells [33]. The presence of HPV 16 E7 was proposed to relieve the requirement of 
certain kinases for RKO viability either by targeting pRb and causing cell cycle progression 
or by targeting other signal transduction pathways. Another finding on simian virus 40 large 
T antigen revealed that pRb binding viral oncoproteins can activate Src by phosphorylation 
via relieving the pRb control [34]. 
In addition to the multiple intracellular pathways affected by papillomaviral oncoproteins, 
one has to consider their effect also on transmembrane tyrosine kinase receptors, since HPV 
has been shown to upregulate EGF-R and the associated focal adhesion kinase as well 
[35,36]. The increased activity of growth factor receptors and the associated signaling 
molecules can also lead to SFK overactivation [37-40]. Nevertheless, a model system of 
culturing homogeneous cell population will more likely detect mechanisms confined to the 
intracellular compartments then exogenous receptor mediated effects requiring cognate 
ligand binding. 
Recent studies focusing on the downstream effects of Src activation in cervical cancer 
suggest that our results describing the phenomenon can be verified by functional assays to 
assess the effect of HPV oncoproteins on migrating or invading properties of the host cell 
[16-18]. In this approach, either mutated HPV oncogenes coding oncoproteins with well 
characterized deficiencies or suppression of HPV oncogene expression by RNA interference 
might be used. Correlating the HPV related SFK alterations to epithelial structure and 
keratinocyte interactions in either organotypic raft cultures or xenograft studies can also 
support our findings in keratinocytes with calcium induced differentiation. 
We believe the present study enlightened an important mechanism of papillomaviral 
oncoproteins which contributes to the development of malignant phenotype of the host 
epithelial cell. Since HPV oncogene expression is necessary to maintain the malignant 
phenotype of cervical cancer cells, the HPV related alterations such as the altered SFK 
expression or activity can be regarded as both initiating and maintaining oncogenic 
mechanisms. 
Conclusion 
In addition to the high constitutive level of Fyn in keratinocytes, the E6 and E7 oncoproteins 
of HPV 16 increase the level of other Src family kinases such as Src and Yes via 
posttranscriptional mechanism. A further effect of HPV 16 E7 oncoprotein is to enhance the 
activating phosphorylation of all available SFKs. Taken together, our findings imply that 
high-risk HPV oncoproteins might influence the activation of SFKs during the development 
of HPV-associated malignancies, which should be taken into consideration during the 
development of treatment strategies with SFK inhibitors for these cancers. 
Materials and methods 
Cell cultures 
Primary neonatal human foreskin keratinocytes (HFK) purchased from Invitrogen were 
transduced with the control LXSN retroviral vector or LXSN-based retroviral vectors 
expressing HPV16 E6, HPV16 E7 or both HPV16 E6 and E7 genes as described previously 
[26]. Infected HFK cells were either cultured in Defined Keratinocyte-Serum Free Medium 
containing < 0.1 mM calcium (DK-SFM, Invitrogen) to promote proliferation or induced to 
differentiate by culturing for 24 h in DMEM (Sigma) containing 1.8 mM calcium and 10% 
fetal calf serum (Gibco). 
Western blot 
Proliferating and differentiating HFK cells were collected by trypsin treatment and whole 
cellular protein extracts were obtained by using RIPA lysis buffer (150 mM NaCl, 1% NP-40, 
50 mM Tris–HCl pH 8.0, 0.5% Na-dezoxycholate, 0.1% SDS, 0.01% Na-azide, 1 mM 
EDTA, pH 7.4) supplemented with Complete EDTA-free Protease Inhibitor Cocktail 
(Roche), 1 mM NaF, and 1 mM Na3VO4. The total protein concentration of the lysates was 
estimated using Bradford protein assay. The extracts were mixed with Laemmli buffer, 
incubated at 95 °C for 5 minutes, and electrophoresed on 10% SDS-polyacrilamide gel. 25 µg 
of each sample was loaded per lane. The separated proteins were electrotransferred onto 
nitrocellulose membrane (GE Healthcare) and after transfer, the membrane was blocked 
using 3% BSA in phosphate-buffered saline (pH 7.2) containing 0.05% Tween20 (PBST). 
Membrane was probed with mouse monoclonal anti-p53 (sc-126, Santa Cruz), mouse 
monoclonal anti-Rb (sc-102, Santa Cruz), mouse monoclonal anti-Src (sc-5266, Santa Cruz), 
mouse monoclonal anti-Yes (sc-48396, Santa Cruz), mouse monoclonal anti-Fyn (sc-271293, 
Santa Cruz), rabbit polyclonal anti-pY416 Src (2101, Cell Signaling), or rabbit polyclonal 
anti-actin (A2066, Sigma) primary antibodies diluted in 3% BSA in PBST. The blot was then 
incubated with a HRP-conjugated goat anti-mouse (sc-2005, Santa Cruz), or HRP-conjugated 
goat anti-rabbit (sc-2004, Santa Cruz) at a dilution of 1:10000 in 3% BSA in PBST for 1 h at 
room temperature. The signals were detected by using SuperSignal West Pico 
Chemiluminescent Substrate (Pierce) followed by exposure to X-ray film (Thermo 
Scientific). 
Phospho-kinase array 
Protein phosphorylation was detected using the Human Phospho-Kinase Array Kit (Proteome 
Prolifer Array, R&D Systems). Total protein extracts were prepared from HFK cells 
transduced by recombinant retroviruses carrying either the control vector (LXSN) or vectors 
encoding HPV 16 E6, E7, or E6/E7. The signals were detected by using SuperSignal West 
Pico Chemiluminescent Substrate (Pierce) followed by exposure to X-ray film (Thermo 
Scientific). The obtained signals were quantified with ImageJ software. 
Quantitative real-time RT-PCR 
Total RNA was isolated from cells using TRI reagent (Sigma) according to the 
manufacturer’s instructions and revers transcribed using the High Capacity cDNA Reverse 
Transcription Kit (Life Technologies). Quantitative real-time PCR was performed on 7500 
Real Time PCR System (Life Technologies) using TaqMan Gene Expression Master Mix and 
Assays according to the manufacturer’s recommendations (all from Life Technologies) at a 
total volume of 20 µl. The applied TaqMan Gene Expression Assays were for Src (SRC; 
Hs01082246_m1), Yes (YES; Hs01080041_g1), Fyn (FYN; Hs00941600_m1), Hck (HCK; 
Hs00176654_m1), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 0711024) as 
endogenous control. Each PCR reaction was performed in triplicate at least three times. 
Statistical analysis 
For the analysis of real-time RT-PCR results, the comparative Ct method was used to obtain 
the Relative Quantification (RQ) values (7500 System SDS Software, version 1.4). Statistical 
anlysis of gene expression data was performed with two-tailed Student t test with P < 0.05 
considered as statistically significant. 
To analyse the results of the phospho-kinase arrays, mean and SEM of standardized spot 
densities were calculated (from two independent experiments with duplicates). 
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